UnitedHealth Group Posts Q2 Revenue Gain
UnitedHealth Group (NYSE:UNH), a leading diversified healthcare and insurance provider, reported results for the second quarter of fiscal 2025 on July 29, 2025. The most significant news was its earnings disappointment: adjusted earnings per share (non-GAAP) came in at $4.08, well below the $4.48 analyst consensus, while revenue (GAAP) was $111.6 billion -- slightly above the $111.5 billion projection.
Even with robust revenue growth, UnitedHealth Group's profitability was weighed down by higher medical costs and a steep drop in operating margins, driven in part by unusually high utilization in its Medicare business earlier in the year and industrywide regulatory headwinds. Overall, the period highlighted strong top-line momentum alongside both operational and margin pressures, with management citing a path to stabilization and renewed growth in 2026.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
Source Fool.com
UnitedHealth Group Inc. Aktie
UnitedHealth Group Inc. erfreut sich großer Beliebtheit, mit einer hohen Zahl an Buy- und niedriger Zahl an Sell-Einschätzungen.
Die Community erwartet für UnitedHealth Group Inc. ein Kursziel von 351 €, was eine Steigerung von über 20% gegenüber 288.3 € bedeuten würde.
